Ferritin as a Marker of Severity in Covid 19 Patients
Phase 3
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B338- Other specified viral diseases
- Registration Number
- CTRI/2021/10/037514
- Lead Sponsor
- Dr TMA PAI HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Lab confirmed COVID 19 by RT-PCR test
2)Patients admitted between APRIL 2020 to
APRIL 2021
3) > 16 years of Age
4)Duration of Admission more than 7 days
Exclusion Criteria
1)COVID -19 RT-PCR Negative
2) < 16 Years of Age
3)Pregnancy
4)Duration of Admission Less than 7 days
5)Patients with prior Renal failure, chronic inflammatory disorders like (RA, Autoimmune disorders, Inflammatory bowel disease, Malignancy)
6)Patients with other infections either preexisting or diagnosed secondary infections after admission
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method correlation of serum ferritin levels with severity of COVID 19 illness (Severe versus Non-Severe Covid 19)Timepoint: APRIL 2020 to APRIL 2021
- Secondary Outcome Measures
Name Time Method Correlation of admission serum ferritin levels with severity of COVID-19 illness to assess its utility as a prognostic marker.Timepoint: APRIL 2020 to APRIL 2021